Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/2003
03/20/2003US20030053982 Interferon attached to water soluble polyethylene glycol
03/20/2003US20030053960 Powder formulation
03/20/2003US20030053959 Breathing a dry powder; antidiabetic agent
03/20/2003CA2764284A1 A system and method for providing closed loop infusion formulation delivery
03/20/2003CA2460509A1 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003CA2460425A1 Novel nucleic acids and polypeptides
03/20/2003CA2460331A1 Use of a protein for the production of a medicament for stimulating the innate non-specific immune system
03/20/2003CA2460117A1 Expression profiling in the intact human heart
03/20/2003CA2460023A1 Method for treating coumarin-induced hemorrhage
03/20/2003CA2459862A1 Oxyntomodulin for preventing or treating excess weight
03/20/2003CA2459769A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses
03/20/2003CA2459442A1 Nucleic acid-associated proteins
03/20/2003CA2459426A1 Human immunodeficiency virus envelope glycoprotein mutants and uses thereof
03/20/2003CA2459367A1 Methods for construction and screening of libraries of chemokine variants
03/20/2003CA2459318A1 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003CA2459310A1 Method and composition for treating immune complex associated disorders
03/20/2003CA2459308A1 Cbi analogues of cc-1065 and the duocarmycins
03/20/2003CA2459307A1 Compositions comprising mixtures of therapeutic proteins and methods of producing the same
03/20/2003CA2459120A1 Human tissue urokinase type plasminogen activator formulation
03/20/2003CA2458543A1 Compositions and methods for treatment of cancer
03/20/2003CA2457851A1 Use of hcg and lh in controlled ovarian hyperstimulation
03/20/2003CA2457849A1 Use of hcg in controlled ovarian hyperstimulation
03/20/2003CA2457282A1 Method for expression of small antiviral rna molecules within a cell
03/20/2003CA2457092A1 Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
03/20/2003CA2457067A1 Use of lh in controlled ovarian hyperstimulation
03/20/2003CA2456561A1 Multiplication of viruses in a cell culture
03/20/2003CA2456310A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003CA2455990A1 Methods for diagnosing and treating diseases and conditions associated with protein kinase c.lambda.
03/20/2003CA2452194A1 Sustained release pharmaceutical compositions comprising a silicone support material
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003CA2451254A1 Novel proteins and nucleic acids encoding same
03/19/2003EP1293570A2 Application of aprataxin gene to diagnosis and treatment for early-onset spinocerebellar ataxia (EAOH)
03/19/2003EP1293568A1 Novel protein and dna thereof
03/19/2003EP1293567A1 Ligand to gpr8 and dna thereof
03/19/2003EP1293566A1 A soluble toll-like receptor
03/19/2003EP1293563A1 Inhibition of apoptosis by the expression of antisense rna of caspase-3
03/19/2003EP1293513A2 A recombinant human factor VIII derivative
03/19/2003EP1293512A2 DNA encoding the baboon and cynomolgus macaque prostaglandin E2 receptor EP4 subtype
03/19/2003EP1293511A1 Canine liver cell growth factor
03/19/2003EP1293510A1 Novel polypeptide and its dna
03/19/2003EP1293207A1 Use of ritonavir (ABT-538) for improving the pharmacokinetics of drugs metabolized by cytochrome P450 in a method of treating aids
03/19/2003EP1293201A2 Use of aminoadamantane compounds as immunoregulators
03/19/2003EP1292709A1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
03/19/2003EP1292705A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human bone marrow
03/19/2003EP1292704A2 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human placenta
03/19/2003EP1292697A2 Method for preparing a physiologically active il-18 polypeptide
03/19/2003EP1292695A2 Gene-regulating conjugates
03/19/2003EP1292694A2 A recombinant non-replicating virus expressing gm-csf and uses thereof to enhance immune responses
03/19/2003EP1292685A2 Human lyases
03/19/2003EP1292684A2 Proteases
03/19/2003EP1292683A2 Secreted redox proteins
03/19/2003EP1292679A1 A g-protein coupled receptor
03/19/2003EP1292678A2 G-protein coupled receptors
03/19/2003EP1292676A1 Mutation associated with epilepsy
03/19/2003EP1292674A2 Nucleotide sequences involved in increasing or decreasing mammalian ovulation rate
03/19/2003EP1292673A2 Thrombomodulin analogs for pharmaceutical use
03/19/2003EP1292620A2 Nuclear hormone receptor
03/19/2003EP1292619A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation
03/19/2003EP1292618A2 Vip-related peptides for the treatment of sexual disorders in women
03/19/2003EP1292616A2 Nucleic acids encoding a regulator of g protein signaling, rgs18, and uses thereof
03/19/2003EP1292612A2 Glycopeptide phosphonate derivatives
03/19/2003EP1292611A2 Glycopeptide carboxy-saccharide derivatives
03/19/2003EP1292610A1 Methods for treating and preventing alopecia
03/19/2003EP1292609A2 Peptides, compositions and methods for the treatment of burkholderia cepacia
03/19/2003EP1292608A2 Novel compounds of the n-acylamino-amide family, compositions comprising same, and uses
03/19/2003EP1292606A2 Positively-charged peptide nucleic acid analogs with improved properties
03/19/2003EP1292605A2 Antisense modulation of inhibitor of dna binding-1 expression
03/19/2003EP1292579A1 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
03/19/2003EP1292568A2 Benzamide ligands for the thyroid receptor
03/19/2003EP1292347A1 Drug delivery apparatus
03/19/2003EP1292337A2 Multivalent platform molecules comprising high molecular weight polyethylene oxide
03/19/2003EP1292326A2 Recombinant human cln2 protein and methods of its production and use
03/19/2003EP1292325A1 Matrix protein compositions for dentin regeneration
03/19/2003EP1292324A2 Critical illness neuropathy
03/19/2003EP1292323A1 Inhibition of smad3 to prevent fibrosis and improve wound healing
03/19/2003EP1292322A1 Immunosuppressor agent derived from morbillivirus
03/19/2003EP1292316A1 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use
03/19/2003EP1292289A2 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
03/19/2003EP1292286A1 Dry-powder pharmaceutical formulation for inhalation comprising alpha4-integrin antagonist
03/19/2003EP1292285A1 Delivery systems for bioactive agents
03/19/2003EP1292283A1 A medicinal aerosol formulation
03/19/2003EP1292279A1 The use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
03/19/2003EP1292278A2 Preparations that contain an extract of the plant pistia stratiotes
03/19/2003EP1292277A1 Method for protecting human skin
03/19/2003EP1292213A1 A formula to manipulate blood glucose via the calculated ingestion of carbohydrate
03/19/2003EP1292187A2 Transgenic animal model of neurodegenerative disorders
03/19/2003EP1292186A1 Animal and cell models for type ii diabetes and their use
03/19/2003EP1196190B1 Use of long-chain n-alkyl derivatives of deoxynojirimycin and a glucocerebrosidase enzyme for the manufacture of a medicament for the treatment of glycolipid storage diseases
03/19/2003EP1151746B1 Microcapsules for sustained release of drugs
03/19/2003EP1116727B1 Peptide derivative
03/19/2003EP1082344B1 Glycoproteins having lipid mobilising properties and therapeutic applications thereof
03/19/2003EP1073485B1 Fully recombinant tissue sealant compositions
03/19/2003EP1034268A4 G-protein coupled receptors and uses therefor
03/19/2003EP0981359B1 Compositions for enhancing immunosuppressants' pharmacological activities
03/19/2003EP0964697B1 Therapeutic applications of antigens or epitopes associated with impaired cellular peptide processing, e.g. expressed on rma-s cells transfected with a b7-1 gene
03/19/2003EP0957935B1 Chlamydial vaccines and immunogenic compositions containing an outer membrane antigen and method of preparation thereof
03/19/2003EP0917472B1 Antiprotozoal composition
03/19/2003EP0876482B1 Il-13 receptor polypeptide
03/19/2003EP0846169B1 MONOCLONAL ANTIBODIES AGAINST SOLUBLE TNF-ALPHA RECEPTORS p55 and p75 AS WELL AS AGAINST TNF-ALPHA AND ITS ANALOGUES
03/19/2003EP0839157B1 Colostrum derived growth factor
1 ... 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 ... 3163